Wright's profits keep sliding; Mindray ticks up revenue;

@FierceMedDev: Freedom Meditech lands $7M for diabetes device. Story | Follow @FierceMedDev

@DamianFierce: Latest in the BRCA battle: Ambry files antitrust suit against Myriad, claiming monopoly. Article | Follow @DamianFierce

@MichaelGFierce: Ocular Therapeutix nets FDA panel meeting for eye surgery hydrogel. More from FierceDrugDelivery | Follow @MichaelGFierce

> The struggling Wright Medical ($WMGI) posted a $15.5 million net loss last quarter, worse than the $1.4 million charge the year before despite increasing revenue 17% to $60.6 million. Results

> Forbes tracks down the little-known Reinhold Schmieding, a clandestine billionaire who made his fortune selling medical devices through his company, Arthrex. Article

> Alere ($ALR) won FDA clearance for MobileLink, a device that transmits patients' vitals and test results to a cloud-based platform. More

> ArthroCare ($ARTC), still working its way out of a fraud scandal that has ex-execs sitting in court, took an $11.1 million loss last quarter, recording a $20.2 million charge related to an ongoing Department of Justice investigation. Item

> Mindray Medical ($MR), China's largest medical device outfit, posted $307.2 million in revenue, a 14.7% increase that drove net income up 19.3% to $62.1 million. News

> OrbusNeich has begun enrolling a postmarket study of the Combo Dual Therapy Stent, planning to recruit 1,000 patients at 9 European sites. Release

Biotech News

@FierceBiotech: Still trending: FDA OKs 5 blockbusters in slow start to 2013 drug approvals. Report | Follow @FierceBiotech

@JohnCFierce: How can you highlight Irish takeover targets and not mention Shire in the lead? Jazz, Alkermes on top. Bloomberg story | Follow @JohnCFierce

@RyanMFierce: Medicines Co. wraps $240M deal to buy ProFibrix following PhIII success. Story | Follow @RyanMFierce

> Novartis grabs lead IL-17 program as Ensemble adds another marquee deal. Report

> Apexigen lands $20M round as China biotech partners advance antibodies. News

> Oncobiologics allies with inVentiv on biosimilars development. Item

Pharma News

@FiercePharma: From FierceVaccines.com: GSK adding 2-D barcode to 4-in-1 flu vaccine packaging. Story  | Follow @FiercePharma

@CarlyHFierce: Bayer says Eylea meets goal in diabetic macular edema trials. Release | Follow @CarlyHFierce

> U.K. cost watchdogs nix Roche's new breast cancer drug Perjeta. Article

> Study: Pharma payments do sway doctors' prescribing habits. Story

> Despite India's Herceptin patent moves, biosimilar rival isn't imminent. More

Pharma Manufacturing News

@EricPFierce: Thermo Fisher has opened what it says is the first DPM plant in Singapore to tap growing biologics market. Article | Follow @EricPFierce

> Merck New Jersey plant to close in October. Story

> GSK adding 2-D barcodes to vaccine containers. Report

> Sanofi to make API for Vivus ED drug Stendra. Item

> Manufacturers' policies put hurt on execution drug supplies. Article

Biotech Research News

> Opioid receptor research could help shape drug development for addiction. More

> Plant-based inhibitor could halt HIV infection. Item

> NIH team sees diabetes drug as a possible tool for extending life. Story

> New hep C model could pave way for novel treatments. Article

> La Jolla, Kyowa Hakko Kirin partner on autoimmune disease drug discovery. More

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.